ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Geriatric Medicine

Top Geriatric Medicine Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
IVAN GELLER MD

Geriatric Medicine

33,791

$2.29M

834
546 are 65+

31%
patients receiving schedule two controlled substances

Avg: 16%

18%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $52

CLEMENCIA RASQUINHA M.D

Geriatric Medicine

25,840

$1.44M

1989
1754 are 65+

32%
patients receiving schedule two controlled substances

Avg: 16%

18%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $52

PAUL FISHMAN MD

Geriatric Medicine

25,822

$1.34M

658
526 are 65+

31%
patients receiving schedule two controlled substances

Avg: 16%

19%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $52

CHANG KANG M.D.

Geriatric Medicine

21,577

$1.24M

1020
878 are 65+

30%
patients receiving schedule two controlled substances

Avg: 16%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $52

DONALD MURPHY MD

Geriatric Medicine

14,987

$801K

1532
1375 are 65+

17%
patients receiving schedule two controlled substances

Avg: 16%

9%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $52

TIMOTHY RODGERS M. D.

Geriatric Medicine

14,893

$883K

819
705 are 65+

20%
patients receiving schedule two controlled substances

Avg: 16%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $52

SHAD GRUBBS MD

Geriatric Medicine

11,781

$600K

454
397 are 65+

17%
patients receiving schedule two controlled substances

Avg: 16%

15%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $52

SCOT SICKBERT M.D., L.L.C.

Geriatric Medicine

11,690

$34.7K

217
167 are 65+

25%
patients receiving schedule two controlled substances

Avg: 16%

20%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$3
Average prescription price

Avg: $52

STUART FERGUSON M.D.

Geriatric Medicine

11,036

$509K

459
367 are 65+

22%
patients receiving schedule two controlled substances

Avg: 16%

22%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $52

BOOKANAKERE NIRANJAN M.D., M.P.H.

Geriatric Medicine

10,790

$559K

452
421 are 65+

23%
patients receiving schedule two controlled substances

Avg: 16%

13%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $52

MICHAEL TODD M.D.

Geriatric Medicine

9,576

$618K

311
302 are 65+

12%
patients receiving schedule two controlled substances

Avg: 16%

10%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $52

ERIKA ALTNEU MD

Geriatric Medicine

8,857

$420K

671
633 are 65+

10%
patients receiving schedule two controlled substances

Avg: 16%

12%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $52

THOMAS CAIN M.D.

Geriatric Medicine

7,894

$342K

621
579 are 65+

10%
patients receiving schedule two controlled substances

Avg: 16%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $52

COURTNEY HALL MD

Geriatric Medicine

7,229

$226K

294
282 are 65+

20%
patients receiving schedule two controlled substances

Avg: 16%

16%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$31
Average prescription price

Avg: $52

JAMES MARTAU M.D.

Geriatric Medicine

7,143

$362K

462
455 are 65+

8%
patients receiving schedule two controlled substances

Avg: 16%

13%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $52

LESLIE REITMAN MD

Geriatric Medicine

6,725

$224K

350
332 are 65+

19%
patients receiving schedule two controlled substances

Avg: 16%

12%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$33
Average prescription price

Avg: $52

JEFFREY KULP MD

Geriatric Medicine

6,486

$358K

353
344 are 65+

5%
patients receiving schedule two controlled substances

Avg: 16%

10%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $52

BOBBIE LIVINGSTON MD

Geriatric Medicine

6,363

$344K

390
349 are 65+

9%
patients receiving schedule two controlled substances

Avg: 16%

13%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $52

PAUL WRIGHT M.D.

Geriatric Medicine

6,139

$231K

275
262 are 65+

24%
patients receiving schedule two controlled substances

Avg: 16%

8%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $52

MITCHEL ROSSMAN M.D.

Geriatric Medicine

5,752

$363K

414
408 are 65+

7%
patients receiving schedule two controlled substances

Avg: 16%

12%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $52

WILLIAM SOLOMON MD

Geriatric Medicine

5,565

$249K

149
136 are 65+

21%
patients receiving schedule two controlled substances

Avg: 16%

22%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $52

JAMES MCGOWAN MD

Geriatric Medicine

5,232

$312K

551
446 are 65+

14%
patients receiving schedule two controlled substances

Avg: 16%

9%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $52

MADHU REDDY M.D.

Geriatric Medicine

5,026

$203K

194
157 are 65+

16%
patients receiving schedule two controlled substances

Avg: 16%

16%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $52

AMIR OBBEHAT M.D.

Geriatric Medicine

4,839

$204K

361
301 are 65+

16%
patients receiving schedule two controlled substances

Avg: 16%

12%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $52

ROBIN YASUI MD

Geriatric Medicine

4,778

$140K

254
246 are 65+

6%
patients receiving schedule two controlled substances

Avg: 16%

12%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$29
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank